IntrinsiQ Expands Oncology’s Gold-Standard for Patient Data Collection

WALTHAM, Mass.--(BUSINESS WIRE)--IntrinsiQ, LLC, the leading provider of U.S. oncology market data and business analytics to pharmaceutical, biotechnology and financial companies today launched IntelliTraQ™, the industry’s most comprehensive Web-based survey tool for cancer drug usage.
MORE ON THIS TOPIC